N
OCEA

Nuveen’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Nuveen’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,704
Closed -$45.6K – 3369
2023
Q3 		$45.6K Hold
11,704
– – ﹤0.01% 3159
2023
Q2 		$70.3K Buy
+11,704
New +$68.6K ﹤0.01% 3181

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

Nuveen's OCEA Position: Q4 2023 in Review

Nuveen sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q4 2023, closing a stake of 11,704 shares — an estimated $45.6K sold.

Nuveen first reported a position in OCEA in Q2 2023 and held it in 2 quarters. The position peaked at $70.3K in Q2 2023. 35 funds tracked by Wall St. Rank hold OCEA as of Q4 2023.

  • Nuveen reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Nuveen sold 11,704 Ocean Biomedical, Inc. Common Stock shares in Q4 2023, an estimated $45.6K.
  • Nuveen first reported a position in Ocean Biomedical, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Nuveen's Ocean Biomedical, Inc. Common Stock position peaked at $70.3K in Q2 2023.
  • 35 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q4 2023.

Based on Nuveen's 13F filing for Q4 2023, filed 14 Feb 2024.